- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Stonegate, Inc.: Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26 | 425 | Newsfile | Dallas, Texas--(Newsfile Corp. - October 1, 2026) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). IXHL's FY26... ► Artikel lesen | |
| 25.09. | Incannex Healthcare Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 09.09. | Incannex begins Phase 2 dosing study for sleep apnea drug | 2 | Investing.com | ||
| INCANNEX HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 09.09. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.08. | Incannex Healthcare: Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X | 221 | GlobeNewswire (Europe) | NEW YORK and MELBOURNE, Australia, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| 25.08. | Incannex Healthcare Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 11.08. | Incannex receives final A$5.1m R&D tax incentive refund | 2 | Investing.com | ||
| 11.08. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.07. | Incannex Healthcare: Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea | 305 | GlobeNewswire (Europe) | First clinical sites approved and actively screening potential participantsRepresents another major milestone in the advancement of IHL-42X towards Phase III developmentIHL-42X has received FDA Fast... ► Artikel lesen | |
| 23.07. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.06. | Incannex receives U.S. patent for sleep apnea drug IHL-42X | 2 | Investing.com | ||
| 25.06. | Incannex Healthcare: Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea | 650 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| 25.06. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.06. | Incannex Healthcare: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility | 527 | GlobeNewswire (Europe) | NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| 09.06. | Incannex Healthcare: Incannex Announces Initiation of Research Coverage by Alliance Global Partners | 380 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| 09.06. | Incannex Healthcare Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | Incannex Healthcare Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.05. | Incannex launches DReAMzz study for sleep apnea treatment | 2 | Investing.com | ||
| 14.05. | Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea | 660 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for... ► Artikel lesen | |
| 12.05. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,350 | +0,16 % | BRANDMELDUNG: Jetzt wird es für die Eckert&Ziegler-Aktie richtig gefährlich - Unbedingt vor Börsenstart am Montag lesen! | ||
| MCKESSON | 790,60 | -1,40 % | McKesson Extends CVS Health Pact To 2032, Reaffirms FY27 Adj. EPS Guidance | WOONSOCKET (dpa-AFX) - Pharmaceutical distributor McKesson Corp. (MCK), announced on Thursday that it has signed an agreement in principle to extend its partnership with CVS Health Corp. (CVS)... ► Artikel lesen | |
| SENSEONICS | 8,800 | 0,00 % | TD Cowen bestätigt Kaufempfehlung für Senseonics Aktie aufgrund von Wachstumstreibern | ||
| PERSPECTIVE THERAPEUTICS | 2,388 | -2,45 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Announces Acceptance of [212Pb]VMT01 Data for Presentation at SITC 2026 | SEATTLE, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering... ► Artikel lesen | |
| SRX GLOBAL | 1,595 | 0,00 % | SRX Global Inc: SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO) | NORTH PALM BEACH, Fla., Sept. 24, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company" or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value... ► Artikel lesen | |
| ITONIC | 0,241 | -3,05 % | iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026 | BEIJING, China, Oct. 02, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (Nasdaq: ITOC) (the "Company"), a healthcare company developing digital medical technologies, today announced that at the extraordinary... ► Artikel lesen | |
| FRESENIUS | 43,635 | -0,38 % | Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA | DJ Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA
DOW JONES--Die Fresenius-Tochter Kabi hat einen Warnschuss von der US-Gesundheitsbehörde FDA erhalten. In dem am Dienstag veröffentlichten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,860 | +0,66 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Accela sei ein Quantensprung in der Strahlentherapie... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,550 | -0,33 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,830 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | +0,03 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| BILLIONTOONE | 105,90 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| HEARTFLOW | 49,270 | -0,10 % | AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion | ||
| PROCEPT BIOROBOTICS | 17,160 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 7,945 | 0,00 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? |
Das Unternehmen INCANNEX HEALTHCARE INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 3,210 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INCANNEX HEALTHCARE INC finden Sie auf Wallstreet Online.